Zobrazeno 1 - 8
of 8
pro vyhledávání: '"A D, Charap"'
Autor:
Ronald Gaster, Richard A. Lewis, Jess Smith, Efraim Duzman, Leon G. Partamian, John C. Lue, Thaddeus Wandel, Arthur D. Charap, Gary D. Novack, Stephen Cobb
Publikováno v:
American Journal of Ophthalmology. 101:298-304
Although twice-daily instillation of topical beta-blockers is the standard regimen for treatment of increased intraocular pressure, once-daily therapy might improve patient compliance and provide greater safety. In a three-month, double-masked clinic
Publikováno v:
Psychopharmacologia. 32:365-371
The effects of alpha-methyl-p-tyrosine (aMpT) on the initial liability to consume oral morphine solution and on withdrawal following cessation of passive morphine administration were assessed. aMpT depressed consumption of oral morphine solution if a
Autor:
D A, Long, G E, Johns, R S, Mullen, R G, Bowe, D, Alexander, D L, Epstein, M J, Weiss, R J, Masi, A D, Charap, C Y, Eto
Publikováno v:
Ophthalmology. 95(6)
In a double-masked, randomized, controlled clinical trial, the authors evaluated the ocular hypotensive efficacy of twice-daily treatment with levobunolol (0.25 and 0.5%) and betaxolol (0.5%) in 85 patients with open-angle glaucoma or ocular hyperten
Autor:
A D, Charap
Publikováno v:
The Mount Sinai journal of medicine, New York. 45(4)
Autor:
A D, Charap, D H, Shin, G, Petursson, D, Cinotti, E, Wortham, R H, Brown, D E, Silverstone, J M, Atkins, C Y, Eto, J C, Lue
Publikováno v:
Annals of ophthalmology. 21(9)
We studied the effects on efficacy and safety of varying the drop size of a topical solution of levobunolol 0.5%. In a double-masked, crossover acute study, we administered a single drop of either 35 microL of vehicle, or 20, 35, or 50 microL of levo
Publikováno v:
Research communications in chemical pathology and pharmacology. 5(3)
Publikováno v:
Psychopharmacologia. 32(4)
Autor:
Arthur D. Charap, Stanley D. Glick
Publikováno v:
Psychopharmacologia. 30(4)
Rats with posterior medial forebrain bundle (PMFB) lesions and control rats were administered morphine chronically for 4 or 5 days via implanted subcutaneous silicone reservoirs. Following cessation of morphine administration after five days, PMFB ra